The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPathfinder Minerals Regulatory News (PFP)

  • This share is currently suspended. It was suspended at a price of 0.275

Share Price Information for Pathfinder Minerals (PFP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.275
PFP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Fundraising

3 Apr 2020 11:37

RNS Number : 7570I
Pathfinder Minerals Plc
03 April 2020
 

3 April 2020

Pathfinder Minerals Plc

 

("Pathfinder" or the "Company")

 

Fundraising

 

Pathfinder is pleased to announce the conditional issue of a £175,000 convertible loan note.

 

Issue of convertible loan notes instrument (the "Instrument")

 

Subject to shareholder approval at a General Meeting to be convened (the "GM"), the Company has entered into binding agreements for the issue of 175,000 convertible loans notes (the "CLNs"), raising, in aggregate, £175,000 (the "Principal Amount") pursuant to subscriptions with a Director of the Company and certain existing and new investors (the "Subscribers").

The key terms of the Instrument are as follows:

Six month term from the date of the first tranche being received by the Company (see following bullet point) which is expected to be 1 June 2020, subject to shareholder approval, with a 16% coupon on an annualised basis.

Principal Amount to be drawn equally over five monthly tranches and interest will be payable only on funds provided to the Company.

In total, at the end of the six month term, the CLNs will have an aggregate principal plus accrued interest balance of £184,359.

Interest will be payable on the maturity date either in cash or in new Ordinary Shares at the Company's election at a price of 0.6p per share. Should an equity raise be conducted prior to the end of the six month term then the interest, if paid in Ordinary Shares, will be payable at the subscription price of the equity raise, if below 0.6p per share.

29,166,666 warrants will be issued to the Subscribers (the "Warrants"). Each Warrant will have an exercise price of 0.6p and be convertible into one Ordinary Share. The Warrants, if not exercised, will expire after two years from the date of the forthcoming GM. Assuming shareholders approve the resolutions at the GM, should an equity fundraising take place prior to 30 April 2021, then the exercise price of any unexercised Warrants will re-strike to the price associated with such equity fundraise, if below 0.6p per share.

A mandatory exercise of the Warrants will be triggered should the Company's share price exceed 1.5p for a period of more than 20 trading days with a volume traded of at least 50 million shares within that period.

On the maturity date, the Company has the right to force the conversion of all or some of the Principal Amount and accrued interest into new Ordinary Shares should the Company determine, acting reasonably, that that it does not have sufficient cash to fund its working capital requirements and to satisfy the repayment of the Principal Amount. Such a conversion would take place at 90% of the 10 day volume weighted average price at the close of trading on the day prior to forced conversion.

 

The Company is required to hold the GM to approve the disapplication of pre-emption rights in relation to, inter alia, the issue of the CLNs and the Warrants. The provision of the Principal Amount to the Company is conditional on the passing of certain resolutions at the GM and shareholders will be strongly encouraged to vote in favour of the resolutions.

 

Related party transaction

 

John Taylor, Chief Executive Officer of Pathfinder, has agreed to subscribe for £25,000 of the CLNs. Such subscription by John Taylor, as a director of the Company, is considered to be a related party transaction pursuant to Rule 13 of the AIM Rules for Companies. The directors of the Company, other than John Taylor, consider, having consulted with the Company's Nominated Adviser, Strand Hanson Limited, that the terms of his subscription are fair and reasonable in so far as the Company's shareholders are concerned.

 

Shareholder approval at the GM

 

The issuance of the CLNs and the Warrants are conditional upon the approval of shareholders of the Company at the GM. In addition, the Board will be seeking further authorities to issue new Ordinary Shares on an ongoing basis. There will be certain conditionality attached to the passing of the resolutions, which will be explained in the requisite circular and Notice of Meeting, which is currently being prepared and is expected to be published shortly.

 

John Taylor, Chief Executive Officer of Pathfinder, commented:

 

"The participation of new and existing investors in this convertible debt financing is a vote of confidence in the strategy that the Board has been pursuing. Despite the ongoing global challenges, it is encouraging that the Company has been able to raise further financing in the current climate, with the potential equity conversion being at a premium to the current share price. The flexibility provided by this short term debt financing and the convertible element associated with it, gives the Company freedom to continue to pursue the recovery of an interest in Mining Licence 4623C."

 

Enquiries:

Pathfinder Minerals Plc

John Taylor, Chief Executive Officer

Tel. +44 (0)20 3440 7775

 

Strand Hanson Limited (Nominated & Financial Adviser and Broker)

James Spinney / Ritchie Balmer / Jack Botros

Tel. +44 (0)20 7409 3494

 

Vigo Communications (Public Relations)

Ben Simons / Simon Woods

Tel. +44 (0)20 7390 0234

Email. pathfinderminerals@vigocomms.com

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR").

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEUOORRRSUSRAR
Date   Source Headline
16th Apr 20247:00 amRNSUpdate on proposed acquisition of Rome Resources
4th Apr 20247:00 amRNSUpdate in relation to £1.275 million subscription
28th Mar 20246:05 pmRNSHolding(s) in Company
27th Feb 20247:00 amRNSUpdate on Rome Resources
29th Jan 202410:21 amRNSAmendment to the revised IM Minerals SPA
2nd Jan 202410:00 amRNSHolding(s) in Company
29th Dec 20231:00 pmRNSTotal Voting Rights
22nd Dec 20239:56 amRNSSubscription to raise £1.275 million and TVR
21st Dec 20235:05 pmRNSResult of General Meeting
4th Dec 20237:00 amRNSNotice of GM
29th Nov 20237:30 amRNSSuspension - Pathfinder Minerals PLC
29th Nov 20237:00 amRNSProposed Acquisition, Subscription & Suspension
3rd Nov 202312:56 pmRNSHolding in Company
26th Sep 20237:00 amRNSHalf-Year Results
1st Sep 20237:00 amRNSProposed Bonus Shares Timetable
18th Aug 20231:42 pmRNSResult of GM & Completion of Disposal
16th Aug 20237:00 amRNSBoard Changes & Proposed Issue of Bonus Shares
31st Jul 20237:00 amRNSNotice of GM
28th Jul 20234:14 pmRNSEntry into revised SPA for sale of IM Minerals
26th Jul 20237:00 amRNSChange of Nominated Adviser and Broker
4th Jul 20234:07 pmRNSHolding(s) in Company
23rd Jun 20237:00 amRNSResult of AGM and Board Changes
19th Jun 20235:04 pmRNSHolding(s) in Company
14th Jun 20234:27 pmRNSUpdate re Sale of IM Minerals
30th May 20233:14 pmRNSUpdate re Sale of IM Minerals
25th May 20237:01 amRNSNotice of AGM
25th May 20237:00 amRNSFinal Results
22nd May 20237:00 amRNSUpdate re Sale of IM Minerals
11th May 20235:00 pmRNSUpdate re Sale of IM Minerals: Result of Meeting
28th Apr 20237:25 amRNSAmendment to Share Option Terms
21st Apr 20237:00 amRNSRevised SPA, Posting of Circular and Notice of GM
12th Apr 20237:00 amRNSUpdate re Sale of IM Minerals
22nd Mar 20232:05 pmRNSSecond Price Monitoring Extn
22nd Mar 20232:00 pmRNSPrice Monitoring Extension
22nd Mar 20237:00 amRNSSPA Signed for Sale of IM Minerals
22nd Feb 20237:00 amRNSUpdate re Sale of IM Minerals
2nd Feb 202311:14 amRNSHolding(s) in Company
1st Feb 20237:01 amRNSUpdate re Bilateral Investment Treaty Claim
1st Feb 20237:00 amRNSPlacing Completion and Total Voting Rights
27th Jan 20235:12 pmRNSResult of General Meeting
9th Jan 20237:00 amRNSNotice of GM
4th Jan 20237:00 amRNSUpdate re Bilateral Investment Treaty Claim
3rd Jan 20237:00 amRNSConditional Placing to Raise £0.5 Million
28th Dec 20223:44 pmRNSUpdate re Loan Agreement
8th Nov 20225:26 pmRNSHolding(s) in Company
30th Sep 20227:00 amRNSHalf-year Results
29th Sep 20227:02 amRNSLoan Agreement
29th Sep 20227:00 amRNSUpdate re Bilateral Investment Treaty Claim
30th Jun 20224:14 pmRNSResult of Annual General Meeting
17th Jun 20224:58 pmRNSNotice of AGM Explanatory Notes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.